Miyamoto, S., Azuma, K., Ishii, H., Bessho, A., Hosokawa, S., Fukamatsu, N., . . . Okamoto, H. (2020). Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation–Positive Non–Small Cell Lung Cancer: A Multicenter Phase 2 Trial. JAMA Oncol.
Citação norma ChicagoMiyamoto, Shingo, et al. "Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation–Positive Non–Small Cell Lung Cancer: A Multicenter Phase 2 Trial." JAMA Oncol 2020.
Citação norma MLAMiyamoto, Shingo, et al. "Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation–Positive Non–Small Cell Lung Cancer: A Multicenter Phase 2 Trial." JAMA Oncol 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.